| Basic Pediatric Series Recommendation for Immunization |
| 4 doses: | 2 months, 4 months, 6 months, 12-15 months |
Note: - Catch-up dosing for children less than 5-years-old: see CDC guidelines.
- May also benefit older children and adults with compromised immunity who have not been previously vaccinated.
|
1. What is this vaccine?
This is a vaccine to prevent young children from infection with Haemophilus influenzae type b bacteria. Some high-risk older adults or children may also need the vaccine.
2. Why is this vaccine important?
The Haemophilus influenzae type b bacteria can cause very serious diseases including meningitis, pneumonia, epiglottitis, blood infection, bone infection, joint infection, pericarditis (infection of the outer covering of the heart), and even death. Most commonly these infections occur in children under 5 years of age. If a child gets Haemophilus influenzae meningitis and survives, there can still be long-term neurological complications.
3. How is this vaccine given?
This vaccine is usually given in the outer mid-thigh muscle or deltoid muscle.
4. What are the risks and special considerations of this vaccine?
This vaccine is not given to infants less than 6 weeks old, since this could reduce the immune response to subsequent doses. Most people do not have problems with the vaccine. It can cause redness, swelling, or warmth at the site of injection. Fever can also occur. Severe reactions, like high fever or difficulty breathing, should be evaluated immediately. Other needed vaccines may be given at the same visit but at different sites. Older children and adults with sickle cell disease, HIV/AIDS, no spleen, bone marrow transplant, or immunosuppression may benefit from the vaccine if they have not been previously vaccinated. This vaccine is not recommended for pregnant or breastfeeding women.
The 6 month pediatric dose is not needed if using the PedvaxHIB® or ComVax® versions.
Individuals with prior severe reactions to this vaccine may not be able to receive another dose. Check with your doctor regarding this issue and for any other contraindications for this vaccine. Also check with your doctor to find out what other ingredients may be in the vaccine, its container, or any diluent in case of allergies or other concerns. Immunization is usually postponed for individuals with a moderate or severe acute illness.
5. Risk factors for contraction of disease
- Age < 5 years old
- Sickle cell disease
- HIV/AIDS
- Immunosuppression
- No spleen
- Bone marrow transplant
Available brands of this vaccine include:
- ACTHib®
- OmniHIB®
- PedvaxHIB®
- ComVax® (PedvaxHIB® combined with Recombivax HB® Hepatitis B vaccine)
- TriHIBit® (ACTHib® combined with DTaP TripediaTM vaccine; for children 12 months of age or older, for the 4th dose of a DTaP/Hib series)
- Pentacel® (ACTHib® combined with inactivated polio vaccine and DTaP)
Citations
- "Recommended Immunization Schedule for Persons Aged 0 Through 18 Years --- United States, 2010." MMWR Weekly. Centers for Disease Control and Prevention. January 2010. http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5851a6.htm?s_cid=mm5851a6_e.
- "Recommended Adult Immunization Schedule --- United States, 2010." MMWR Weekly. Centers for Disease Control and Prevention. January 2010. http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5901a5.htm?s_cid=mm5901a5.
- "Haemophilus Influenzae Type b (Hib) Vaccine What You Need to Know." U.S. Department of Health and Human Services. Centers for Disease Control and Prevention. National Immunization Program Vaccine Information Statement. December 1998. www.cdc.gov/vaccines/pubs/vis/downloads/vis-hib.pdf.
- "Haemophilus b Conjugate Vaccine (Tetanus Toxoid Conjugate) ActHIB®." Aventis Pasteur. December 2005. http://www.vaccineshoppe.com/image.cfm?image_type=product_pdfπ=545-05.
- "Liquid PedvaxHIB® [Haemophilus b Conjugate Vaccine (Meningococcal Protein Conjugate)]." Merck and Co., Inc. January 2001. http://www.merck.com/product/usa/pi_circulars/p/pedvax_hib/pedvax_pi.pdf.
- "COMVAX® [Haemophilus b Conjugate (Meningococcal Protein Conjugate) and Hepatitis B (Recombinant) Vaccine]." Merck and Co., Inc. August 2004. http://www.merck.com/product/usa/pi_circulars/c/comvax/comvax_pi.pdf.
- "Diptheria and Tetanus Toxoids and Acellular Pertussis Adsorbed, Inactivated Poliovirus and Haemophilus b Conjugate (Tetanus Toxoid Conjugate) Vaccine: Pentacel®." Sanofi Pasteur. June 2008. http://www.vaccineshoppe.com/image.cfm?pi=510-05&image_type=product_pdf.
- "Combination Vaccines: TriHIBit®." Centers for Disease Control and Prevention. http://www2.cdc.gov/nip/isd/ycts/mod1/courses/dtp/10405.asp.
- "Vaccine Excipient and Media Summary." U.S. Department of Health and Human Services. Centers for Disease Control and Prevention. http://www.cdc.gov/vaccines/pubs/pinkbook/downloads/appendices/B/excipient-table-1.pdf.
- "Vaccine Excipient and Media Summary, Part 2." U.S. Department of Health and Human Services. Centers for Disease Control and Prevention. April 2009. http://www.cdc.gov/vaccines/pubs/pinkbook/downloads/appendices/B/excipient-table-2.pdf.
- "Thimerosol in Vaccines." U.S. Food and Drug Administration. Center for Biologics Evaluation and Research. November 2009. http://www.fda.gov/cber/vaccine/thimerosal.htm.
Created: 7/2/2007
Last Modified: 3/13/2010